Russell Investments Group Ltd. raised its position in LHC Group (NASDAQ:LHCG) by 94.5% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,743 shares of the health services provider’s stock after purchasing an additional 5,220 shares during the period. Russell Investments Group Ltd. owned 0.06% of LHC Group worth $729,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also recently made changes to their positions in LHCG. BlackRock Inc. increased its position in shares of LHC Group by 43,223.7% in the 1st quarter. BlackRock Inc. now owns 1,969,496 shares of the health services provider’s stock valued at $106,157,000 after purchasing an additional 1,964,950 shares during the last quarter. Point72 Asset Management L.P. increased its position in shares of LHC Group by 292.3% in the 1st quarter. Point72 Asset Management L.P. now owns 439,399 shares of the health services provider’s stock valued at $23,684,000 after purchasing an additional 327,399 shares during the last quarter. FMR LLC increased its position in shares of LHC Group by 14.1% in the 1st quarter. FMR LLC now owns 1,619,899 shares of the health services provider’s stock valued at $87,312,000 after purchasing an additional 199,849 shares during the last quarter. Eagle Asset Management Inc. purchased a new stake in shares of LHC Group in the 1st quarter valued at approximately $6,414,000. Finally, Kennedy Capital Management Inc. purchased a new stake in shares of LHC Group in the 1st quarter valued at approximately $5,369,000. 85.93% of the stock is currently owned by institutional investors.
In related news, COO Donald Dwayne Stelly sold 2,650 shares of LHC Group stock in a transaction on Friday, September 8th. The shares were sold at an average price of $65.34, for a total value of $173,151.00. Following the completion of the sale, the chief operating officer now owns 109,235 shares in the company, valued at $7,137,414.90. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 14.80% of the stock is currently owned by insiders.
Shares of LHC Group (NASDAQ:LHCG) traded up 1.17% on Friday, hitting $65.57. 419,301 shares of the stock traded hands. The firm’s 50-day moving average is $63.46 and its 200 day moving average is $59.66. LHC Group has a 12-month low of $32.04 and a 12-month high of $69.35. The firm has a market cap of $1.20 billion, a P/E ratio of 29.01 and a beta of 0.76.
LHC Group (NASDAQ:LHCG) last issued its quarterly earnings results on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.09. The business had revenue of $260.20 million during the quarter, compared to analyst estimates of $254.10 million. LHC Group had a net margin of 4.13% and a return on equity of 9.62%. The business’s revenue was up 15.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.52 earnings per share. Equities research analysts forecast that LHC Group will post $2.39 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “LHC Group (LHCG) Holdings Raised by Russell Investments Group Ltd.” was first published by TrueBlueTribune and is owned by of TrueBlueTribune. If you are reading this piece on another domain, it was illegally copied and republished in violation of international trademark and copyright legislation. The legal version of this piece can be viewed at https://www.truebluetribune.com/2017/09/17/lhc-group-lhcg-holdings-raised-by-russell-investments-group-ltd.html.
A number of equities research analysts have commented on the stock. Royal Bank Of Canada reissued a “buy” rating and issued a $70.00 price objective on shares of LHC Group in a research report on Wednesday, September 6th. Zacks Investment Research raised shares of LHC Group from a “hold” rating to a “buy” rating and set a $67.00 price objective on the stock in a research report on Saturday, August 5th. BidaskClub raised shares of LHC Group from a “hold” rating to a “buy” rating in a research report on Friday, August 18th. Benchmark Co. increased their price objective on shares of LHC Group from $63.00 to $72.00 and gave the company a “buy” rating in a research report on Thursday, June 8th. Finally, Jefferies Group LLC reissued a “buy” rating and issued a $65.00 price objective on shares of LHC Group in a research report on Friday, June 9th. One research analyst has rated the stock with a hold rating and ten have assigned a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $66.60.
LHC Group Company Profile
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group (NASDAQ:LHCG).
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.